Integrated BioPharma Inc. | Cash Flow
Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
93.00
131.00
735.00
958.00
2,346.00
679
Depreciation, Depletion & Amortization
425.00
390.00
405.00
351.00
393.00
348
Other Funds
500.00
399.00
433.00
300.00
616.00
68
Funds from Operations
1,018.00
920.00
707.00
1,609.00
2,532.00
1,111
Changes in Working Capital
2,456.00
957.00
820.00
2,203.00
2,135.00
57
Net Operating Cash Flow
1,438.00
1,877.00
113.00
594.00
397.00
1,168
Capital Expenditures
30.00
182.00
235.00
109.00
327.00
Sale of Fixed Assets & Businesses
19.00
-
-
2.00
-
Purchase/Sale of Investments
-
-
79.00
-
-
Net Investing Cash Flow
11.00
182.00
156.00
107.00
327.00
Issuance/Reduction of Debt, Net
1,359.00
1,303.00
111.00
1,025.00
336.00
Net Financing Cash Flow
1,359.00
1,299.00
111.00
1,025.00
333.00
Net Change in Cash
90.00
396.00
380.00
324.00
263.00
Free Cash Flow
1,468.00
1,695.00
348.00
703.00
70.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
823.00
152
Change in Capital Stock
-
4.00
-
-
3.00
About Integrated BioPharma
View Profile
